Burswood-based Resonance Health has announced it will open a second TrialsWest facility in WA to provide better access to clinic trials, after acquiring the company in April.
Our weekly appointments wrap includes David Coyne, Lisa Wynne, Jérôme Pécresse, Neil Brodie, Benjamin Carruthers, Ash Colmer, Fiona Payne, Trent Barlett, Stephen Butcher, Rosemarie Myers, Clare Cullen and Paul Lyons.
Our board moves wrap includes Kristie Young, Andrew Strickland, Jonathan Downes, Josh Merriman, Catherine Grant-Edwards, Melissa Chapman, Melissa North, Liesl Ellies, Patrick O'Connor, Sonu Cheema, Matthew Foy, and Guy Debelle.
Healthcare tech and services company Resonance Health has won a $6.33 million contract from a multinational pharmaceutical company, subject to clinical trial approvals.
Our board moves wrap includes Sonu Cheema, Steve Samuel, Michelle Guthrie, Rowan Harland, Arron Canicais, Nick Woolrych, Patrick Holywell, and Nick Allan.
Our board moves wrap includes Andrew Metcalfe, George Lazarou, María Claudia Pohl Ibáñez, Christopher Chalwell, Michael Winlo, Brett Crowley, Erlyn Dawson, and Aaron Brinkworth.
Our weekly appointments wrap includes Meriel Steadman, Ben Gargett, Krista Bates, Emma Ramage, Christina Matthews, John Olynyk, Cathy Falkiner, Rob Scott, Mike Henry, Matt Comyn and Jeremy Taylor.
Our board moves wrap includes Walter Joseph, Heng Fai Chan, Blair Michelson, Mitchell Wells, Demetrios Pynes, Mauro Piccini, Jeremy King, Peter Wall, and Andrew Frazer.
Our board moves wrap includes Michael Tomasz, Hugh Callaghan, Jamie Myers, Alison Laws, Mitchell Wells, Ben Wyatt, Ian Tan-Kang, Darren Holden, and Ian Murray.
Our board moves wrap includes Geoff Goldsmith, Giuseppe Di Franco, Andrew Lane, Nick Allan, Agha Shahzad, Mitchell Wells, Christian Viguie, Nicolas Clerc, and Martin Bennett.
Shares in Resonance Health have doubled today after its FerriSmart technology, which uses machine learning to quantify liver iron concentration, received FDA approval.
Newly established Perth company OncoRes Medical has secured up to $6 million of funding to commercialise a surgical tool developed by researchers at the Harry Perkins Institute of Medical Research and the University of Western Australia.
Shares in Resonance Health jumped 53 per cent today after its FerriScan technology was recommended for use under a new set of medical guidelines in the UK.
Medical technology may have taken a back seat to resources stocks during the mining boom, but the sector has generated a lot more interest of late, with several players in reverse takeovers on the ASX.
Local biotech firm Sun Biomedical has announced plans to buy Melbourne-based Dimerix Bioscience in exchange for a share package worth about $8.3 million.
Improving the diagnosis and management of patients with fatty liver conditions was the motivation for the 2014 WA Innovator of the Year winner, Resonance Health.
FEATURE: The state's biotechnology sector is heating up as investors look for the next wave of investment opportunities amid waning resources investment.
As a boy, Tim St Pierre loved playing with his magnets; now he's a physics professor who is passionate about linking physics and biology through magnetic resonance imagery.
Claremont-based magnetic resonance imaging technology developer Resonance Health Ltd has extended the distribution deal for its liver iron monitoring device FerriScan with Switzerland-based Novartis AG, the company has announced.
Resonance Health Limited has received an interim stop order from ASIC due to concerns over estimated research and development costs and cash flow assumptions.
CLAREMONT-BASED healthcare company Resonance Health Ltd this week announced a deeply discounted $3.06 million entitlements offer at two cents per share to fund further development of FibroScreen, a no
Claremont based healthcare company Resonance Health Ltd today announced a deeply discounted $3.06 million entitlements offer at two cents per share to fund further development of FibroScreen, a non-invasive liver fibrosis test.
Nedlands-based Resonance Health Ltd has announced it has been granted Canadian regulatory clearance by Health Canada for FerriScan, its novel non-invasive diagnostic test for liver iron concentration.
